255 related articles for article (PubMed ID: 26551684)
1. Blood kinetics of Ebola virus in survivors and nonsurvivors.
Lanini S; Portella G; Vairo F; Kobinger GP; Pesenti A; Langer M; Kabia S; Brogiato G; Amone J; Castilletti C; Miccio R; Zumla A; Capobianchi MR; Di Caro A; Strada G; Ippolito G;
J Clin Invest; 2015 Dec; 125(12):4692-8. PubMed ID: 26551684
[TBL] [Abstract][Full Text] [Related]
2. Ebola viral load at diagnosis associates with patient outcome and outbreak evolution.
de La Vega MA; Caleo G; Audet J; Qiu X; Kozak RA; Brooks JI; Kern S; Wolz A; Sprecher A; Greig J; Lokuge K; Kargbo DK; Kargbo B; Di Caro A; Grolla A; Kobasa D; Strong JE; Ippolito G; Van Herp M; Kobinger GP
J Clin Invest; 2015 Dec; 125(12):4421-8. PubMed ID: 26551677
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone.
Ji YJ; Duan XZ; Gao XD; Li L; Li C; Ji D; Li WG; Wang LF; Meng YH; Yang X; Ling BF; Song XA; Gu ML; Jiang T; Koroma SM; Bangalie J; Duan HJ
Infect Dis Poverty; 2016 Nov; 5(1):101. PubMed ID: 27806732
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory and Humoral Immune Response during Ebola Virus Infection in Survivor and Fatal Cases Occurred in Sierra Leone during the 2014⁻2016 Outbreak in West Africa.
Colavita F; Biava M; Castilletti C; Lanini S; Miccio R; Portella G; Vairo F; Ippolito G; Capobianchi MR; Di Caro A; Lalle E
Viruses; 2019 Apr; 11(4):. PubMed ID: 31018522
[TBL] [Abstract][Full Text] [Related]
5. Persistence of Ebola virus in semen among Ebola virus disease survivors in Sierra Leone: A cohort study of frequency, duration, and risk factors.
Thorson AE; Deen GF; Bernstein KT; Liu WJ; Yamba F; Habib N; Sesay FR; Gaillard P; Massaquoi TA; McDonald SLR; Zhang Y; Durski KN; Singaravelu S; Ervin E; Liu H; Coursier A; Marrinan JE; Ariyarajah A; Carino M; Formenty P; Ströher U; Lamunu M; Wu G; Sahr F; Xu W; Knust B; Broutet N;
PLoS Med; 2021 Feb; 18(2):e1003273. PubMed ID: 33566817
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States.
Liddell AM; Davey RT; Mehta AK; Varkey JB; Kraft CS; Tseggay GK; Badidi O; Faust AC; Brown KV; Suffredini AF; Barrett K; Wolcott MJ; Marconi VC; Lyon GM; Weinstein GL; Weinmeister K; Sutton S; Hazbun M; Albariño CG; Reed Z; Cannon D; Ströher U; Feldman M; Ribner BS; Lane HC; Fauci AS; Uyeki TM
Ann Intern Med; 2015 Jul; 163(2):81-90. PubMed ID: 25961438
[TBL] [Abstract][Full Text] [Related]
7. Ebola virus antibody decay-stimulation in a high proportion of survivors.
Adaken C; Scott JT; Sharma R; Gopal R; Dicks S; Niazi S; Ijaz S; Edwards T; Smith CC; Cole CP; Kamara P; Kargbo O; Doughty HA; van Griensven J; Horby PW; Gevao SM; Sahr F; ; Dimelow RJ; Tedder RS; Semple MG; Paxton WA; Pollakis G
Nature; 2021 Feb; 590(7846):468-472. PubMed ID: 33505020
[TBL] [Abstract][Full Text] [Related]
8. Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone.
Shantha JG; Mattia JG; Goba A; Barnes KG; Ebrahim FK; Kraft CS; Hayek BR; Hartnett JN; Shaffer JG; Schieffelin JS; Sandi JD; Momoh M; Jalloh S; Grant DS; Dierberg K; Chang J; Mishra S; Chan AK; Fowler R; O'Dempsey T; Kaluma E; Hendricks T; Reiners R; Reiners M; Gess LA; ONeill K; Kamara S; Wurie A; Mansaray M; Acharya NR; Liu WJ; Bavari S; Palacios G; Teshome M; Crozier I; Farmer PE; Uyeki TM; Bausch DG; Garry RF; Vandy MJ; Yeh S
EBioMedicine; 2018 Apr; 30():217-224. PubMed ID: 29622497
[TBL] [Abstract][Full Text] [Related]
9. The natural history of acute Ebola Virus Disease among patients managed in five Ebola treatment units in West Africa: A retrospective cohort study.
Skrable K; Roshania R; Mallow M; Wolfman V; Siakor M; Levine AC
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005700. PubMed ID: 28723900
[TBL] [Abstract][Full Text] [Related]
10. Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea.
Vernet MA; Reynard S; Fizet A; Schaeffer J; Pannetier D; Guedj J; Rives M; Georges N; Garcia-Bonnet N; Sylla AI; Grovogui P; Kerherve JY; Savio C; Savio-Coste S; de Séverac ML; Zloczewski P; Linares S; Harouna S; Abdoul BM; Petitjean F; Samake N; Shepherd S; Kinda M; Koundouno FR; Joxe L; Mateo M; Lecine P; Page A; Tchamdja TM; Schoenhals M; Barbe S; Simon B; Tran-Minh T; Longuet C; L'Hériteau F; Baize S
JCI Insight; 2017 Mar; 2(6):e88864. PubMed ID: 28352651
[No Abstract] [Full Text] [Related]
11. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study.
Lanini S; Portella G; Vairo F; Kobinger GP; Pesenti A; Langer M; Kabia S; Brogiato G; Amone J; Castilletti C; Miccio R; Capobianchi MR; Strada G; Zumla A; Di Caro A; Ippolito G;
Clin Infect Dis; 2018 Jan; 66(1):36-44. PubMed ID: 29020340
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study.
Lado M; Walker NF; Baker P; Haroon S; Brown CS; Youkee D; Studd N; Kessete Q; Maini R; Boyles T; Hanciles E; Wurie A; Kamara TB; Johnson O; Leather AJM
Lancet Infect Dis; 2015 Sep; 15(9):1024-1033. PubMed ID: 26213248
[TBL] [Abstract][Full Text] [Related]
14. Statistical methodologies for evaluation of the rate of persistence of Ebola virus in semen of male survivors in Sierra Leone.
Habib N; Hughes MD; Broutet N; Thorson A; Gaillard P; Landoulsi S; McDonald SLR; Formenty P;
PLoS One; 2022; 17(10):e0274755. PubMed ID: 36197875
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features of Patients With Ebola Virus Disease in Sierra Leone.
Qin E; Bi J; Zhao M; Wang Y; Guo T; Yan T; Li Z; Sun J; Zhang J; Chen S; Wu Y; Li J; Zhong Y
Clin Infect Dis; 2015 Aug; 61(4):491-5. PubMed ID: 25995207
[TBL] [Abstract][Full Text] [Related]
16. Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques.
Wong G; Qiu X; de La Vega MA; Fernando L; Wei H; Bello A; Fausther-Bovendo H; Audet J; Kroeker A; Kozak R; Tran K; He S; Tierney K; Soule G; Moffat E; Günther S; Gao GF; Strong J; Embury-Hyatt C; Kobinger G
J Infect Dis; 2016 Oct; 214(suppl 3):S281-S289. PubMed ID: 27651412
[TBL] [Abstract][Full Text] [Related]
17. Deaths, late deaths, and role of infecting dose in Ebola virus disease in Sierra Leone: retrospective cohort study.
Bower H; Smout E; Bangura MS; Kamara O; Turay C; Johnson S; Oza S; Checchi F; Glynn JR
BMJ; 2016 May; 353():i2403. PubMed ID: 27188404
[TBL] [Abstract][Full Text] [Related]
18. Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus.
Rollin PE; Bausch DG; Sanchez A
J Infect Dis; 2007 Nov; 196 Suppl 2():S364-71. PubMed ID: 17940972
[TBL] [Abstract][Full Text] [Related]
19. Viraemia and Ebola virus secretion in survivors of Ebola virus disease in Sierra Leone: a cross-sectional cohort study.
Green E; Hunt L; Ross JCG; Nissen NM; Curran T; Badhan A; Sutherland KA; Richards J; Lee JS; Allen SH; Laird S; Blackman M; Collacott I; Parker PA; Walbridge A; Phillips R; Sellu SJ; Dama A; Sheriff AK; Zombo J; Ngegba D; Wurie AH; Checchi F; Brooks TJ
Lancet Infect Dis; 2016 Sep; 16(9):1052-1056. PubMed ID: 27197552
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of viral load in patients with Ebola virus disease in Liberia: a retrospective observational study.
Jeremiah Matson M; Ricotta E; Feldmann F; Massaquoi M; Sprecher A; Giuliani R; Edwards JK; Rosenke K; de Wit E; Feldmann H; Chertow DS; Munster VJ
Lancet Microbe; 2022 Jul; 3(7):e533-e542. PubMed ID: 35617976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
